Besides epigenetic dysregulation, various signaling pathways are activated by genetic events in pediatric brain tumors, e.g., MAPK in LGG, SHH and WNT signaling in MB and ETMR, SHH and TYR in ATRT [3,7,86]. The gene discussed is SHH; the disease is brain neoplasm.